Table: begin end state 1 20 cytoplasmic 21 46 transmembrane 47 56 non-cytoplasmic 57 78 transmembrane 79 86 cytoplasmic 87 109 transmembrane 110 110 non-cytoplasmic 111 111 transmembrane 112 116 non-cytoplasmic 117 140 transmembrane 141 151 cytoplasmic 152 175 transmembrane 176 186 non-cytoplasmic 187 207 transmembrane 208 244 cytoplasmic 245 265 transmembrane 266 277 non-cytoplasmic 278 297 transmembrane 298 308 cytoplasmic 309 327 transmembrane 328 332 non-cytoplasmic 333 357 transmembrane 358 371 cytoplasmic 372 394 transmembrane 395 399 non-cytoplasmic 400 420 transmembrane 421 445 cytoplasmic
Input: >PP_2411 MSAHHEVSPATLRRVIAASAIGNFVEWFDFAVYGFLATLIASQFFASEDASVALLKTFAV FAVAFALRPLGGIVFGALGDRLGRKRILSLTILLMAGSTTLIGLLPTYASIGLAAPALLT LARCLQGFSAGGEYAGACAYLMEHAPDDKRAFYGSFVPVSTFSAFACAAVIAYGLEASLS TEAMNAWGWRIPFLIAAPLGLVGLYLRWRMEETPAFREAVAQGKEHEHSPLKETLRHHGR VIRNLGAFISLTALSFYMFTTYFATYLQLVGNLTRAQSLLVTTVALLFAAVGCPLAGAFS DRVGRRKTIGFTCLWVMLCVFPAYWLASSGSMSGALLGVILLAVGALCSGVVTAALLSES FPTRTRYTASAITYNVAYTLFGGTAPLVATWLIAQTGSSLAPAFYLVVIALVALVGGLAL PETSRISLHDDLGVDGVRAGARRAV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server